The Association of Clinical Research Organizations is introducing a new series of videos featuring the leaders of prominent healthcare interest groups.
The first two videos feature Ladd Wiley, Executive Director of the Alliance for a Stronger FDA, and Michael Reilly, Executive Director of the Alliance for Safe Biologic Medicines.
“ACRO participates in several alliances and coalitions to help amplify our message about the importance of clinical research,” said John Lewis, Vice President of Public Affairs. “We thank Ladd and Michael for helping us kick-off this series by discussing the important topics of adequate funding for the FDA and regulatory matters surrounding biosimilars. We plan several additional videos covering issues such as incentives for medical research, regenerative medicine, comparative effectiveness research and the business environment for life sciences in India.”
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
Optimizing Phase III Oncology Trial Recruitment with Data-Driven Insights
February 3rd 2025A pharmaceutical company aimed to launch a Phase III clinical trial for a new oncology drug, focusing on efficient and effective patient recruitment across diverse regions. They evaluated patient populations by analyzing demographics, social determinants of health, and geography. Investigator profiling included practice details, affiliations, referral networks, and clinical trial experience. The final step involved selecting and extracting target lists for implementation.